Canale-Theakston Carin 4
4 · Cidara Therapeutics, Inc. · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Canale-Theakston Carin
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-18+11,100→ 11,100 totalExercise: $21.31Exp: 2035-06-17→ Common Stock (11,100 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on the earlier of (i) June 18, 2026 or (ii) the day prior to the date of the Issuer's 2026 annual meeting of stockholders.